Health & Well-Being
UConn Health Researchers Receive a $3.1 Million Dollar Grant to Study Pandemic-Related Stress in Families with Infants
Damion Grasso and Margaret Briggs-Gowan developed a tool to measure pandemic-related stress. They are now applying it in a study focused on families who gave birth and are now raising infants during the pandemic
Bringing ‘Behavioral Vaccines’ to School: 5 Ways Educators Can Support Student Well-Being
Simple steps that educators and parents can take to help support child well-being throughout the day
Meet the Researcher: Jayesh Kamath, School of Medicine
Jayesh Kamath is bringing psychiatry into the mobile tech era by using mHealth technologies to support patients with depression
Parents Confused about Healthier Drinks for Kids Not Helped by Labeling of Fruit Drinks, Flavored Water and Unsweetened Juice
Clearer disclosures about added sugars, diet sweeteners and percent juice on product packages are needed to address widespread misperceptions about ingredients in popular children’s drinks
Power of a Phone Call: Medical Students Changing COVID-19 Patients’ Lives
Students have made more than 2,500 phone calls to COVID-19 patients and isolated seniors since the start of the pandemic
PODCAST: A Clear Voice on Vocal Health
Two founders of UConn Health's Voice and Speech Clinic join the UConn Health Pulse podcast to discuss voice disorders and how their practice helps voice users of all levels.
Spring Sneeze Season has Sprung
Sunshine and spring sneezes are here. UConn Health's ENT/allergy expert Dr. Todd Falcone shares how spring allergies to pollen can lead to your sneezes, but also sometimes just simply sunlight too.
Psoriasis Center Brings Together Patients, Providers, and Researchers
UConn Health has transformed its former John Dempsey Hospital emergency department space into a center for its dermatologists to provide coordinated care of psoriasis patients.
High-Profile Brain Tumor Therapy Trial Chooses UConn Health
An immunotherapy derived from the polio virus has shown improved survival rates in early-phase trials in patients with an aggressive type of brain tumor known as glioblastoma. UConn Health will be one of a select few sites in the U.S. for the second phase, which will pair it with the cancer immunotherapy pembrolizumab (Keytruda).
How Safe is Baby Food? Company Reports Show Arsenic, Lead, and Other Heavy Metals
Since the amount of heavy metals varies so dramatically, food choices can make a difference.